IVF HARTMANN Holding AG

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CH0187624256
CHF
138.00
-1 (-0.72%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About IVF HARTMANN Holding AG stock-summary
stock-summary
IVF HARTMANN Holding AG
Pharmaceuticals & Biotechnology
IVF HARTMANN Holding AG (IVF) is a Switzerland-based holding company engaged in the field of medical supplies. The Company's product range includes bandages, rheumatism plasters, baby products, feminine hygiene, cotton wool, first aid, diagnostics equipment, X-ray protection clothing, among others. The Company’s main clients usually are hospitals, doctors, surgery centers, care centers, pharmacies, drugstores, wholesalers and corporate medical centers. The Company also offers consulting services, on-site or in classrooms, related to the usage of its products. The Company's activities are divided into research and development, distribution logistics, production planning, purchase and four production segments: Coating; Medical Products; Elastic Bandages, and Hygiene Products. It also operates subsidiaries located in Switzerland.
Company Coordinates stock-summary
Company Details
Victor-von-Bruns-Strasse 28 , NEUHAUSEN AM RHEINFALL None : 8212
stock-summary
Tel: 41 52 6743111
stock-summary
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summary Board of Directorsstock-summary
Management
Designation
Dr. Rinaldo Riguzzi
Non-Executive Chairman of the Board of Directors
Dr. Walter Schweizer
Non-Executive Vice Chairman of the Board of Directors
Mr. Fritz Hirsbrunner
Non-Executive Member of the Board of Directors
Mr. Andreas Joehle
Delegate of the Board of Directors
Mr. Michel Kuehn
Non-Executive Member of the Board of Directors
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
(Quarterly Results - )
Net Profit:
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

CHF 334 Million ()

stock-summary
P/E

17.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

4.46%

stock-summary
Debt Equity

-0.62

stock-summary
Return on Equity

13.08%

stock-summary
Price to Book

2.29